Latest Technology Platforms News

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.

BetMakers Technology Group launches a $13.5 million equity raise to fund the acquisition of Las Vegas Dissemination Company and strengthen its financial position amid improving operational metrics.

BetMakers Technology Group has raised A$12.5 million through an institutional placement and plans a further A$1 million via a Share Purchase Plan, positioning itself for strategic expansion and debt repayment.

Catapult Group International has acquired Perch, an AI-driven athlete monitoring startup, for US$18 million, enhancing its Performance & Health vertical without raising capital. This move integrates gym-based strength data with on-field analytics, promising a more comprehensive sports technology platform.

Judo Capital Holdings Limited reaffirmed its FY25 guidance at its 2025 Investor Day, highlighting strong lending growth, a maturing technology platform, and a focused strategy to optimize its SME banking model.

Atturra Limited has completed its acquisition of DalRae Solutions, a specialist SAP consultancy, aiming to deepen its footprint in SAP services across Australia and New Zealand. The deal includes upfront and performance-based payments totalling up to $20 million.

Xamble Group has acquired a 19% stake in Malaysia’s leading loyalty platform B Infinite, aiming to deepen influencer marketing engagement and unlock new revenue streams across Southeast Asia.

Aroa Biosurgery has reported a robust 23% revenue increase in FY25, achieving profitability and positive cash flow, setting the stage for continued growth in FY26.

Noxopharm has secured ethics approval to commence the HERACLES trial, marking the first human study of its novel SOF-SKN™ drug aimed at chronic inflammatory diseases.

Web Travel Group Limited reported a robust 22% increase in Total Transaction Value for FY25, despite a 14% dip in EBITDA due to margin pressures and higher costs. The company is strategically investing in supply and technology to target $10 billion TTV by FY30.

Smartpay Holdings Limited posted solid FY25 financials with revenue surpassing $104 million, driven by Australian market gains and promising New Zealand pilot progress. The company is advancing its trans-Tasman payments strategy amid regulatory developments.